demonstrated that B cells suppressed T cell-dependent tumor immunity and the low immunogenicity of tumors was caused by B cells, whose presence in the priming phase results in disabled CD4 T cells that help CTL-mediated tumor immunity (43). This evidence concerns the gene CD4 and neoplasm.